The BioMed Alliance would like to express its strong support for the ERNs and laud the European Commission for its crucial, indispensable role in establishing them. We are convinced of the great potential of these networks, not just for diagnosis and treatment but also for research. We therefore call upon the European Commission to ensure the success and continuity of the ERNs by making available solid and long-term funding.

Read more here

The BioMed Alliance welcomes the European Commission's proposed budget for the next Framework Programme for Research and Innovation (Horizon Europe). We would like to take this opportunity to express our full support for an ambitious Horizon Europe, and to thank you for your commitment to promoting research as a main priority in the Multiannual Financial Framework (MFF) budget. A strong Horizon Europe will continue the track record of Horizon 2020, and will foster scientific excellence in Europe.

The BioMed Alliance, while acknowledging the multiple societal challenges that Horizon Europe has to address, is convinced that in terms of value for money, health research should be a top funding priority considering its significance for the wellbeing of EU citizens and as a driver of economic growth

Read more here

The BioMed Alliance welcomes the European Commission’s proposed budget for the next Framework Programme for Research and Innovation (Horizon Europe) within the Multiannual Financial Framework (MFF). A budget of 100 billion euro for Horizon Europe represents an increase of almost 30 per cent, and it is essential to provide effective solutions to societal challenges and foster scientific excellence in Europe.
The BioMed Alliance calls on the European Commission, European Parliament, and the Council of the EU to secure a robust budget for health research under Horizon Europe. 25-30% of the Horizon Europe budget dedicated to biomedical and health-related research will ensure a coherent, competitive European research landscape, and it will generate societal benefits and long term positive economic impact.

More info here

Better funded and better organised research programmes are an urgent priority for the health of us all.

Read the article here

Although the benefits of EU-funded health research are easy to see, such funding does not reflect the high return on investment that it provides. It will need to be substantially increased before it can do so.

More here

The subject is too important for everyone – patients, the public, and the economy – to suffer from the effect of fragmented messages.

Read more here 

The European Calcified Tissue Society (ECTS) is a non-for profit organisation in Europe for researchers and clinicians working in the field of calcified tissues and related fields. Our mission is to promote excellence in research into the field of calcified tissues within Europe and beyond, and to ensure the findings are disseminated to enable benefit to patients with metabolic bone disease.  ECTS represents more than 600 members at all stages of career and has a network of over 30 national and international societies.  More information at www.ectsoc.org.

ECTS expertise and fully support will help BioMed Alliance to provide recommendations for policy and decision makers on facilitating and mproving biomedical research in Europe.  

Read the interview with Prof. Axel Pries – President of the BioMed Alliance and Prof. Gunhild Waldemar – member of the BioMed Alliance Board of Directors. Read the article here.

BioMed Alliance Member Organisations elected him at the General Assembly on 8 November 2017  for a two-year period.

Download the PDF

BioMed Alliance Board of Director Ulrich Jaeger argues that EU funding is crucial in allowing medical researchers across member states to collaborate in the development of new treatments. In Framework Programme 9, processes must be optimised and the budget boosted - to deliver for patients and the economy.  Read the article here

Experts discuss the FEAM-BioMed Alliance Paper in Open Access Government. The FEAM-BioMed Alliance Paper outlines how the next EU Framework Programme can further support biomedical research in Europe. Read the article here.

The European Crohn's and Colitis Organisation (ECCO), founded in 2001 to improve the care of patients with inflammatory bowel disease (IBD) in Europe, is now the largest forum for specialists in IBD in the world. It is a non-profit association, which successfully expanded from an organisation comprising 14 Country Members to an association assembling 36 member states of the Council of Europe and facilitating collaborations beyond Europe's borders. You can find more info here: https://www.ecco-ibd.eu/

Download the PDF

Download the PDF

Fore more info click here

See the newsletter online

Download the PDF

See the newsletter online

See the newsletter online

BioMed Alliance Policy Officer: 8th of November (9:00-12:30), at BioMed Alliance office

General Assembly 2016: 9th of November (9:00 – 16:00), at the Sofitel Le Louise Hotel, Brussels.

An official dinner will be organized on 8th of November (20:00 – 22:00) at the same hotel.

Strategic meeting with Presidents of BioMed Alliance member societies: 29th of November, at BioMed Alliance office.

BioMed Alliance Event in the European Parliament: 29th of November (12:00-14:00)

Download the document